89 related articles for article (PubMed ID: 7662070)
1. Hemodynamic effects of bolus nicorandil compared with nitroglycerin.
Utoh J; Miyauchi Y; Goto H; Obayashi H; Hirata T
Am J Emerg Med; 1995 Sep; 13(5):610-2. PubMed ID: 7662070
[No Abstract] [Full Text] [Related]
2. Comparison of the acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate.
Chibana T; Nagamine F; Sunagawa R; Oshiro K; Nakada Y; Shimabukuro M; Shinzato T; Murakami K; Mimura G; Sakanashi M
Arzneimittelforschung; 1991 Jun; 41(6):591-4. PubMed ID: 1834065
[TBL] [Abstract][Full Text] [Related]
3. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
[TBL] [Abstract][Full Text] [Related]
4. Effects of nicorandil on coronary circulation in patients with ischemic heart disease: comparison with nitroglycerin.
Aizawa T; Ogasawara K; Kato K
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S123-9. PubMed ID: 2447419
[TBL] [Abstract][Full Text] [Related]
5. Nicorandil: differential contribution of K+ channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin.
Borg C; Mondot S; Mestre M; Cavero I
J Pharmacol Exp Ther; 1991 Nov; 259(2):526-34. PubMed ID: 1682478
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium.
Gross GJ; Pieper GM; Warltier DC
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S76-84. PubMed ID: 2447429
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new coronary vasodilator, N-(2-hydroxyethyl)nicotinamide nitrate (SG-75) and nitroglycerin on cardiovascular hemodynamics in young and aged beagle dogs.
Sakai K; Aono J; Haruta K
Jpn J Pharmacol; 1981 Apr; 31(2):281-5. PubMed ID: 6458720
[No Abstract] [Full Text] [Related]
8. Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.
Tsutamoto T; Kinoshita M; Nakae I; Maeda Y; Wada A; Yabe T; Horie H
Am Heart J; 1994 Apr; 127(4 Pt 1):866-73. PubMed ID: 8154425
[TBL] [Abstract][Full Text] [Related]
9. Effects of nicorandil on the conductive coronary artery of the dog.
Imai S; Nakazawa M; Takeda K; Nakagawa Y; Katano Y; Tsukada T; Nabata H; Ushijima T
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S10-6. PubMed ID: 2447415
[TBL] [Abstract][Full Text] [Related]
10. Effects of nicorandil on coronary hemodynamics in ischemic heart disease: comparison with nitroglycerin, nifedipine, and propranolol.
Kobayashi K; Hakuta T
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S109-15. PubMed ID: 2447417
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of nicorandil (SG-75), a new long-acting drug with nitroglycerin effects, in patients with coronary artery disease: improved left ventricular function and regional wall motion and abolition of pacing-induced angina.
Thormann J; Schlepper M; Kramer W; Gottwik M; Kindler M
J Cardiovasc Pharmacol; 1983; 5(3):371-7. PubMed ID: 6191134
[No Abstract] [Full Text] [Related]
12. Differential effects of nifedipine, nicorandil and nitroglycerin on the pressor responses elicited by selective alpha-1 and alpha-adrenoceptor agonists in conscious dogs.
Wynsen JC; Gross GJ; Brooks HL; Warltier DC
J Pharmacol Exp Ther; 1987 Jun; 241(3):846-54. PubMed ID: 2885410
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.
Larsen AI; Gøransson L; Aarsland T; Tamby JF; Dickstein K
Am Heart J; 1997 Sep; 134(3):435-41. PubMed ID: 9327699
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.
Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S
Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic actions of nicorandil, a new antianginal agent, in the conscious dog.
Preuss KC; Gross GJ; Brooks HL; Warltier DC
J Cardiovasc Pharmacol; 1985; 7(4):709-14. PubMed ID: 2410712
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of nicorandil on cardiovascular hemodynamics and left ventricular function.
Kambara H; Nakamura Y; Tamaki S; Kawai C
J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S104-8. PubMed ID: 2447416
[TBL] [Abstract][Full Text] [Related]
17. Left ventricular effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs.
Hashimoto K; Ohbayashi Y; Kinoshita M
Cardiovasc Drugs Ther; 1990 Dec; 4(6):1449-54. PubMed ID: 2150492
[TBL] [Abstract][Full Text] [Related]
18. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
Perrone Filardi P; Chiariello M
Cardiologia; 1995 Dec; 40(12 Suppl 1):87-9. PubMed ID: 8998787
[No Abstract] [Full Text] [Related]
19. Effects of nicorandil on cytosolic calcium concentrations and on tension development in the rabbit femoral artery.
Abe S; Nishimura J; Nakamura M; Kanaide H
J Pharmacol Exp Ther; 1994 Feb; 268(2):762-71. PubMed ID: 8113988
[TBL] [Abstract][Full Text] [Related]
20. [Nicorandil, a potassium channel agonist].
Gerson C
Soins; 1996 Nov; (610):61. PubMed ID: 9016185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
